2025 EVENT SITE
WMIF MAIN SITE
Tuesday, September 16, 2025
09:10 AM - 09:50 AM
Gene therapy and gene editing are transforming how rare and widespread diseases are diagnosed, treated, and prevented. Advances in molecular precision enable tailored interventions at the individual level while supporting scalable solutions for larger populations. This panel will explore how novel gene therapy and editing tools are revolutionizing the diagnosis, treatment and prevention of diseases at an individual and population-based level. Experts will discuss the latest breakthroughs in gene editing and the challenges that come with translating these innovations into widespread and effective clinical care.
Moderator
Benjamin Kleinstiver, PhD,
Investigator, Center for Genomic Medicine; Kayden-Lambert MGH Research Scholar 2023-2028, Mass General Brigham;
Associate Professor of Pathology, Harvard Medical School
Speakers
Omar Abudayyeh, PhD,
Director of Gene Editing, Gene and Cell Therapy Institute, Mass General Brigham;
Assistant Professor of Medicine, Harvard Medical School
Steve Favaloro,
Chairman & CEO, Genezen
David Liu, PhD
Richard Merkin Professor; Director, Merkin Institute of Transformative Technologies in Healthcare, Broad Institute
Trevor Martin, PhD,
Co-founder & CEO, Mammoth Biosciences
Laura Sepp-Lorenzino, PhD,
Senior Advisor, Former CSO, Intellia Therapeutics
© 2025 Mass General Brigham Incorporated. All Rights Reserved